Simrat Randhawa
Chief Tech/Sci/R&D Officer bij DIANTHUS THERAPEUTICS, INC.
Vermogen: 7 500 $ op 31-03-2024
Profiel
Simrat Randhawa is currently the Chief Medical Officer at Dianthus Therapeutics, Inc. Prior to this, he held the position of Head-Medical Affairs at BioMarin Pharmaceutical, Inc. He also served as the Senior Vice President-Clinical & Medical Affairs at Aurinia Pharmaceuticals, Inc. from 2019 to 2022.
Dr. Randhawa holds an MBA from The Trustees of Columbia University in The City of New York and a doctorate from Drexel University College of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 24-01-2024 | 250 ( 0.00% ) | 7 500 $ | 31-03-2024 |
Actieve functies van Simrat Randhawa
| Bedrijven | Functie | Begin |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 11-09-2023 |
Eerdere bekende functies van Simrat Randhawa
| Bedrijven | Functie | Einde |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 01-04-2022 |
| BIOMARIN PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Simrat Randhawa
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| Drexel University College of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
